← Back to Search

Interference through learning of a competing motor skill. for Healthy Subjects (FORGET Trial)

N/A

Waitlist Available

Led By Kirstin-Friederike Heise, PhD

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up six days

Awards & highlights

FORGET Trial Summary

This trial will test the effect of a single behavioral interference intervention on a previously consolidated sensorimotor skill in a large sample of healthy volunteers.

FORGET Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ seven days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~seven days

This trial's timeline: 3 weeks for screening, Varies for treatment, and seven days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Delayed interference rate (change in performance precision)

Immediate interference rate (change in performance precision)

Secondary outcome measures

Learning rate (change in performance precision)

FORGET Trial Design

4Treatment groups

Experimental Treatment

Placebo Group

Group I: Interference on sequences 1 and 2Experimental Treatment1 Intervention

The interference intervention (session six) will be applied to both of the two previously learned sequences (temporal and spatial).

Group II: Interference on sequence 2Experimental Treatment1 Intervention

The interference intervention (session six) will be applied to one of the two previously learned sequences (spatial).

Group III: Interference on sequence 1Experimental Treatment1 Intervention

The interference intervention (session six) will be applied to one of the two previously learned sequences (temporal).

Group IV: No interferencePlacebo Group1 Intervention

The interference intervention (session six) will be applied.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Interference through learning of a competing motor skill.

2022

N/A

~410

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of General Medical Sciences (NIGMS)NIH

269 Previous Clinical Trials

246,708 Total Patients Enrolled

Medical University of South CarolinaLead Sponsor

934 Previous Clinical Trials

7,394,392 Total Patients Enrolled

Kirstin-Friederike Heise, PhDPrincipal InvestigatorMedical University of South Carolina

1 Previous Clinical Trials

30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of this research trial in terms of participants?

"Correct. Evidence on clinicaltrials.gov shows that this trial, which was posted for the first time on August 1st 2022, is still recruiting patients. Approximately 412 participants must be sourced from a solitary medical facility."

Answered by AI

Is this experiment currently in need of participants?

"Verified. Clinicaltrials.gov displays that this trial, initiated on August 1st 2022, is still recruiting participants. A total of 412 individuals are being accepted at a single medical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reshaping the Motor Engram - An Online Crowdsourcing Study.

Kirstin-Friederike Heise, PhD 2022. "Reshaping the Motor Engram - An Online Crowdsourcing Study.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05511480.